COVID-19: CCR1 antagonist for the treatment of hospitalised COVID-19 patients (CATCOVID) - study coordination
- Funded by Federal Ministry of Research, Technology and Space (BMFTR)
- Total publications:0 publications
Grant number: 16LW0008
Grant search
Key facts
Disease
COVID-19Start & end year
20212023Known Financial Commitments (USD)
$2,737,449.79Funder
Federal Ministry of Research, Technology and Space (BMFTR)Research Location
GermanyLead Research Institution
Charité - Universitätsmedizin BerlinResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
N/ASpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
UnspecifiedBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified